课题基金 / 基金详情

Glomerular cross-talk between podocytes and parietal epithelial cells: the role of platelet-derived growth factors (PDGFs)

Glomerular cross-talk between podocytes and parietal epithelial cells: the role of platelet-derived growth factors (PDGFs)
足细胞和壁上皮细胞之间的肾小球串扰:血小板衍生生长因子(PDGF)的作用
批准号:
210828308
负责人:
Professor Dr. Peter Boor, Ph.D.
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2012
资助国家:
德国
项目状态:
已结题
起止时间:
2011-12-31 至 2015-12-31

项目摘要

项目成果

Professor Dr. Peter Boor, Ph.D.的其他基金

相似基金

相关文献

中文摘要
翻译
肾小球硬化(FSGS)是所有进行性肾小球疾病的终点。新月体肾小球肾炎(GN)是一种肾脏急症,常导致FSGS。本病以肾小球毛细血管外细胞增生物的形成为特征。除狼疮和血管炎外,新月体也可发生在许多肾小球肾炎中,当新月体出现时,表明病程严重。在先前的研究中,我们已经表明:a)肾小球Bowman囊内周的细胞,即壁上皮细胞(佩奇),在FSGS和新月体的形成中起关键作用; B)小鼠足细胞中血小板衍生生长因子(PDGF)-DD过表达导致新月体和系膜增生性GN;(4)肾小球内PDGF受体阳性细胞主要为系膜细胞和佩奇。在这里,我们假设,PDGF是重要的有丝分裂原和佩奇的促纤维化激活剂,从而介导新月体GN和FSGS。为了解决这一假设,我们将使用我们自己独特的工具,包括PDGF-DD缺陷小鼠,PDGF-DD中和抗体和PEC报告小鼠。这些将用于新月体GN和FSGS模型。原代鼠PEC将用于体外实验。
英文摘要
Glomerulosclerosis (FSGS) is the end-point of all progressive glomerular diseases. The nephrologicalemergency, crescentic glomerulonephritis (GN), frequently leads to FSGS. This disease ischaracterized by the formation of glomerular extracapillary cellular proliferates. Apart from lupus andvasculitides, crescents can occur in many GNs and, when present, indicate a severe disease course.In prior studies we have shown that a) the cells lining the inner circumference of the glomerularBowman’s capsule, i.e. parietal epithelial cells (PECs), are crucially involved in both FSGS andcrescent formation; b) that platelet-derived growth factor (PDGF)-DD overexpression in podocytes inmice leads to crescentic and mesangioproliferative GN; c) that PDGFs are potent mitogens andprofibrotic factors for glomerular cells; d) that in glomeruli PDGF receptor-bearing cells mainly includemesangial cells and PECs. Here, we hypothesize, that PDGFs are important mitogens and profibroticactivators of PECs, thereby mediating both crescentic GN and FSGS. To address this hypothesis, wewill use our own unique tools including PDGF-DD deficient mice, PDGF-DD neutralizing antibody, andPEC reporter mice. These will be employed in models of crescentic GN and FSGS. Primary murinePECs will be used in in vitro experiments.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1681/asn.2013040376
发表时间: 2014
期刊: Journal of the American Society of Nephrology : JASN
影响因子: --
作者: [Kevin A. Schulte;Katja Berger;P. Boor;Peggy Jirak;I. Gelman;K. Arkill;C. Neal;W. Kriz;J. Floege;B. Smeets;M. Moeller]
通讯作者: Kevin A. Schulte;Katja Berger;P. Boor;Peggy Jirak;I. Gelman;K. Arkill;C. Neal;W. Kriz;J. Floege;B. Smeets;M. Moeller
Translational Nephropathology
  • 批准号:
    454024652
  • 项目类别:
    Heisenberg Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Professor Dr. Peter Boor, Ph.D.
  • 依托单位:
Role of epithelial CD74 in renal diseases
  • 批准号:
    432698239
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Professor Dr. Peter Boor, Ph.D.
  • 依托单位:
Translational Nephropathology
  • 批准号:
    329501625
  • 项目类别:
    Heisenberg Fellowships
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Professor Dr. Peter Boor, Ph.D.
  • 依托单位:
Translationale Nephropathologie
  • 批准号:
    388978824
  • 项目类别:
    Heisenberg Professorships
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Professor Dr. Peter Boor, Ph.D.
  • 依托单位:
国内基金
海外基金
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
  • 批准号:
    JCZRYB202500379
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
SCFAs-HDAC/HAT的“肠—脑”cross-talk干预环境铅汞镉联合致衰老相关认知障碍
  • 批准号:
    82560652
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32.00万元
  • 批准年份:
    2025
  • 负责人:
    谢杰
  • 依托单位: